United Kingdom
As Associate Director of Market Access for UK & Ireland at Jazz, my job is to get our treatments available on the NHS as quickly as possible for patients and their families. At Chiesi, I worked in the Global HEOR and UK/Ireland Market Access teams, leading on economic evidence generation for 4 rare disease therapies across US and Europe/International, including economic modelling and outcomes research. I led successful UK HTA submissions (NICE, SMC, AWMSG, NCPE) and value communications across the Chiesi portfolio, including Respiratory, Rare Diseases and Special Care. Prior to joining Chiesi, I was Associate Director of Market Access at RTI Health Solutions and a Technical Analyst at NICE, evaluating medical devices and diagnostic tests for use in the NHS. I am a PhD scientist by training with over 10 years' research experience in cancer cell biology at Oxford University and the University of Manchester, with industrial experience at AstraZeneca. Specialities: health technology assessment, medical devices, medical diagnostics, medical communications, medical education, medical event management, molecular biology, rare disease, oncology, cancer cell biology, diabetes, endocrinology, obesity, biochemistry, project management, health economics and outcomes research #HTA #HEOR #RareDisease #Oncology